| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-07 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |